Altered peptide ligands narrow the repertoire of cellular immune responses by interfering with T-cell priming

Nature Medicine

Volumn 5, Issue 5, 1999, Pages 565-571

  Plebanski, Magdalena ^a   Lee, Edwin A M ^a   Hannan, Carolyn M ^a   Flanagan, Katie L ^a   Gilbert, Sarah C ^b   Gravenor, Michael B ^c   Hill, Adrian V S ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; LIGAND; PEPTIDE; T LYMPHOCYTE ANTIGEN; T LYMPHOCYTE RECEPTOR;

ADOLESCENT; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; MALARIA; MOUSE; NONHUMAN; PERSISTENT INFECTION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; T LYMPHOCYTE;

ANTIGEN PRESENTATION; ANTIGENIC VARIATION; ANTIGENS, PROTOZOAN; EPITOPES; HUMANS; LIGANDS; LYMPHOCYTE ACTIVATION; MALARIA, FALCIPARUM; PEPTIDE FRAGMENTS; PROTOZOAN PROTEINS; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032948455     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/8444     Document Type: Article

References (43)

1. Phillips, R.E. et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354, 453-459 (1991).
2. Couillin, I. et al. Impaired cytotoxic T lymphocyte recognition due to genetic variations in the main immunogenic region of the human immunodeficiency virus 1 NEF protein. J. Exp. Med. 180, 1129-1134 (1994).
3. Klenerman, P. et al. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants. Nature 369, 403-407 (1994).
4. Bertoletti, A. et al. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 369, 407-410 (1994).
5. Davenport, M.P. Antagonists or altruists: do viral mutants modulate T-cell responses? Immunol. Today. 16, 432-436 (1995).
6. Nowak, M.A. et al. Antigenic oscillations and shifting immunodominance in HIV-1 infections [see comments]. Nature 375, 606-611 (1995).
7. Nowak, M.A. & Bangham, C.R. Population dynamics of immune responses to persistent viruses. Science 272, 74-79 (1996).
8. Gilbert, S.C. et al. Association of malaria parasite population structure, HLA, and immunological antagonism. Science 279, 1173-1177 (1998).
9. Gupta, S. & Hill, A.V.S. Dynamic interactions in malaria: Host heterogeneity meets parasite polymorphism. Proc. R. Soc. Lond. B Biol. Sci. 261, 271-277 (1995).
10. Plebanski, M., Allsopp, C.E.M., Aidoo, M., Reyburn, H. & Hill, A.V.S. Induction of peptide-specific primary cytotoxic T lymphocyte responses from human peripheral blood. Eur. J. Immunol. 25, 1783-1787 (1995).
11. Nardin, E.H. & Nussenzweig, R.S. T cell responses to pre-erythrocytic stages of malaria: role in protection and vaccine development against pre-erythrocytic stages. Annu. Rev. Immunol. 11, 687-727 (1993).
12. Hoffman, S.L. et al. Sporozoite vaccine induces genetically restricted T cell elimination of malaria from hepatocytes. Science 244, 1078-1081 (1989).
13. Romero, P. et al. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria. Nature. 341, 323-326 (1989).
14. Hill, A.V.S. et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature. 360, 434-439 (1992).
15. Aidoo, M. et al. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet 345, 1003-1007 (1995).
16. Klenerman, P., Meier, U.C., Phillips, R. E. & McMichael, A.J. The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus. Eur. J. Immurol. 25, 1927-1931 (1995).
17. Kaneko, T. et al. Impaired induction of cytotoxic T lymphocytes by antagonism of weak agonist borne by a variant hepatitis C virus epitope. Eur. J. Immunol. 27, 1782-1787 (1997).
18. Daniel, C., Grakoui, A. & Allen, P.M. Inhibition of an in vitro CD4+ T cell alloresponse using altered peptide ligands. J. Immunol. 60, 3244-3250 (1998).
19. Ruppert, J. et al. MHC blocking peptides and T-cell receptor antagonists: novel paths to selective immunosuppression? Chem. Immunol. 60, 61-78 (1995).
20. Sette, A. et al. Antigen analogs/MHC complexes as specific T cell receptor antagonists. Annu. Rev. Immunol. 12, 413-431 (1994).
21. Jameson, S.C., Carbone, F.R. & Bevan, M.J. Clone-specific T cell receptor antagonists of major histocompatibility complex class I-restricted cytotoxic T cells. J. Exp. Med. 177, 1541-1550 (1993).
22. Benjamin, K.V., Hsu, B.L., Williams, C.B. & Allen, P.M. Endogenous altered peptide ligands can affect peripheral T cell responses. J. Exp. Med. 183, 1311-1321 (1996).
23. Smith, K.J. et al. An altered position of the alpha 2 helix of MHC class 1 is revealed by the crystal structure of HLA-B*3501. Immunity 4, 203-213 (1996).
24. Garboczi, D.N. et al. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 384, 134-141 (1996).
25. Garcia, K. C. et al. An alphabeta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 274, 209-219 (1996).
26. Page, D.M. et al. Negative selection of CD4+ CD8+ thymocytes by T-cell receptor peptide antagonists. Proc. Natl. Acad. Sci. USA 91, 4057-4061 (1994).
27. Sloan Lancaster, J., Evavold, B.D. & Allen, P.M. Induction of T-cell anergy by altered T-cell-receptor ligand on live antigen-presenting cells. Nature 363, 156-159 (1993).
28. Pfeiffer, C. et al. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J. Exp. Med. 181, 1569-1574 (1995).
29. Kumar, V. et al. Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon gamma by T cells. Proc. Natl. Acad. Sci. USA 92, 5510-9514 (1995).
30. Evavold, B.D. & Allen, P.M. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. Science 252, 1308-1310 (1991).
31. Evavold, B.D., Sloan Lancaster, J., Hsu, B.L. & Allen, P.M. Separation of T helper 1 clone cytolysis from proliferation and lymphokine production using analog peptides. J. Immunol. 150, 3131-3140 (1993).
32. Karin, N., Mitchell, D.J., Brocke, S., Ling, N. & Steinman, L. Reversal of experimental autoimmune encephalomyelitis by a soluble peptide variant of a myelin basic protein epitope: T cell receptor antagonism and reduction of interferon gamma and tumor necrosis factor alpha production. J. Exp. Med. 180, 2227-2237 (1994).
33. Windhagen, A. et al. Modulation of cytokine patterns of human autoreactive T cell clones by a single amino acid substitution of their peptide ligand. Immunity 2, 373-380 (1995).
34. Hollsberg, P. et al. Differential activation of proliferation and cytotoxicity in human T-cell lymphotropic virus type I Tax-specific CD8 T cells by an altered peptide ligand. Proc. Natl. Acad. Sci. USA 92, 4036-4040 (1995).
35. Plebanski, M. et al. Protection from Plasmodium berghei infection by priming and boosting T cells to a single class I restricted epitope with recombinant carriers suitable for human use. Eur. J. Immunol. 28, 4345-4355 (1998).
36. Schneider, J. et al. Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara. Nature Med. 4, 397-402 (1998).
37. Doolan, D.L. et al. Circumventing genetic restriction of protection against malaria with multigene DNA Immunization: CD8+ T cell-, Interferon γ-, and Nitric Oxide-dependant immunity. J. Exp. Med. 183, 1739-1746 (1996).
38. Bodmer, H.C., Pemberton, R.M., Rothbard, J.B. & Askonas, B.A. Enhanced recognition of a modified peptide antigen by cytotoxic T cells specific for influenza nucleoprotein. Cell 52, 253-258 (1988).
39. Apostolopoulos, V., Pietersz, G.A. & McKenzie, I.F.C. Cell-mediated immune responses to MUC1 fusion protein coupled to mannan. Vaccine 14, 930-938 (1996).
40. Gilbert, S.C. et al. A protein particle vaccine containing multiple malaria epitopes. Nature Biotech. 15, 1280-1284 (1997).
41. Espevik, T. & Nissen Meyer, J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Meth. 95, 99-105 (1986).
42. Moss, P.A., Rosenberg, W.M., Zintzaras, E. & Bell, J.I. Characterization of the human T cell receptor alpha-chain repertoire and demonstration of a genetic influence on V alpha usage. Eur. J. Immunol. 23, 1153-1159 (1993).
43. Plebanski, M., Aidoo, M., Whittle, H.C. & Hill, A.V.S. Precursor frequency analysis of cytotoxic T lymphocytes to pre-erythrocytic antigens of Plasmodium falciparum in West Africa. J. Immunol. 158, 2849-2855 (1997).